Scarica l'app Stockscreener
14.77
20.63%
-3.84
Dopo l'orario di chiusura:
14.89
0.12
+0.81%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NEO Giù?
Forum
Previsione
Frazionamento azionario
Neogenomics Inc Borsa (NEO) Ultime notizie
NeoGenomics Shares Fall on CEO's Plan to Retire - MarketWatch
NeoGenomics' (NEO) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
NeoGenomics (NEO) Shares Cross Below 200 DMA - Nasdaq
NeoGenomics Shares Are Falling Today: What's Going On? - Benzinga
NeoGenomics (NASDAQ:NEO) Shares Gap DownTime to Sell? - MarketBeat
NeoGenomics CEO steps down, shares fall 17% By Investing.com - Investing.com Canada
NeoGenomics (NASDAQ:NEO) Releases FY 2024 Earnings Guidance - MarketBeat
NeoGenomics (NEO) CEO Chris Smith to retire - StreetInsider.com
NeoGenomics, Inc. Reaffirms Earnings Guidance for Full Year Ended December 31, 2024 - Marketscreener.com
NeoGenomics Appoints Tony Zook As CEO - citybiz
NeoGenomics CEO Chris Smith to Retire; Tony Zook to Take Helm - MarketWatch
NeoGenomics Announces CEO Transition and Leadership Change - TipRanks
NeoGenomics Announces Chief Executive Officer Succession - The Bakersfield Californian
Neogenomics, Announces Retirement of Chris Smith as Board Member, Effective April 1, 2025 - Marketscreener.com
Leerink Partnrs Weighs in on NeoGenomics FY2024 Earnings - MarketBeat
NeoGenomics (NASDAQ:NEO) Sets New 12-Month HighShould You Buy? - MarketBeat
NeoGenomics stock hits 52-week high at $19.01 amid growth By Investing.com - Investing.com South Africa
NeoGenomics stock hits 52-week high at $19.01 amid growth - Investing.com
NeoGenomics CEO to Present Strategic Vision at J.P. Morgan Healthcare Conference - StockTitan
NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Bakersfield Californian
NeoGenomics (NEO) Upgraded to Buy: Here's Why - MSN
The past three years for NeoGenomics (NASDAQ:NEO) investors has not been profitable - Simply Wall St
IBD Rating Upgrades: NeoGenomics Flashes Improved Price Strength - MSN
NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
NeoGenomics, Inc. (NASDAQ:NEO) Shares Acquired by Geode Capital Management LLC - MarketBeat
Franklin Resources Inc. Has $28.23 Million Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
NeoGenomics, Inc. (NASDAQ:NEO) Shares Bought by State Street Corp - MarketBeat
Natera expands lawsuit against NeoGenomics over RaDaR test By Investing.com - Investing.com Canada
Natera expands lawsuit against NeoGenomics over RaDaR test - Investing.com India
Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics - Business Wire
Bank of America Raises NeoGenomics (NASDAQ:NEO) Price Target to $19.00 - Defense World
NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma - BioSpace
BNP Paribas Financial Markets Boosts Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
NeoGenomics' Breakthrough Study Shows Promise in Early Melanoma Detection Using RaDaR® Technology - StockTitan
Evaluating NeoGenomics: Insights From 4 Financial Analysts - Benzinga
NeoGenomics Getting Closer To Key Technical Measure - MSN
NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting - Business Wire
Charles Schwab Investment Management Inc. Acquires 57,677 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
NeoGenomics Inc (NEO) Trading 4.33% Higher on Dec 6 - GuruFocus.com
ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research - The Cancer Letter
Edgestream Partners L.P. Sells 94,791 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research - Business Wire
ConcertAI, NeoGenomics Launch Groundbreaking 370,000-Patient Hematology Research Platform - StockTitan
NeoGenomics, Inc. (NASDAQ:NEO) Shares Purchased by Bellevue Group AG - MarketBeat
NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Mutual of America Capital Management LLC Sells 1,716 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
Algert Global LLC Has $1.18 Million Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
Natixis Advisors LLC Buys 11,936 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
Loomis Sayles & Co. L P Purchases Shares of 1,207,290 NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
(NEO) Investment Analysis - Stock Traders Daily
NeoGenomics, Inc. (NASDAQ:NEO) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - Simply Wall St
NeoGenomics, Inc. (NASDAQ:NEO) Stock Holdings Raised by Jennison Associates LLC - MarketBeat
NeoGenomics Inc (NEO) Shares Up 4.09% on Nov 22 - GuruFocus.com
0.99%
1.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):